T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Thursday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 0.4 %

Shares of TTOO opened at $0.11 on Thursday. The business’s fifty day moving average is $0.15 and its 200 day moving average is $0.63. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.